One company, Edwards Lifesciences, wants to own the entire market for a new heart valve technology.

TL;DR Edwards Lifesciences already dominates the existing heart valve market and tried to buy the only other company developing a next-generation valve for a fatal heart condition affecting at least 8 million Americans. The technology at stake, called TAVR-AR, isβ¦






